Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 7, 2013, Pages 1129-1133

  Jagasia, Madan ^a   Greinix, Hildegard ^b   Robin, Marie ^c   Das Gupta, Emma ^d   Jacobs, Ryan ^a   Savani, Bipin N ^a   Engelhardt, Brian G ^a   Kassim, Adetola ^a   Worel, Nina ^b   Knobler, Robert ^b   Russell, Nigel ^d   Socie, Gerard ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Acute graft versus host disease; Allogeneic hematopoietic cell transplantation; Extracorporeal photopheresis; Steroid refractory

Indexed keywords

CORTICOSTEROID; ETANERCEPT; INOLIMOMAB; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EXTRACORPOREAL PHOTOPHERESIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOTHERAPY; SALVAGE THERAPY; SURVIVAL; TREATMENT RESPONSE;

ACUTE DISEASE; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PHOTOPHERESIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84879382652     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.04.018     Document Type: Article

References (18)

1. Jagasia M., Arora M., Flowers M.E., et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012, 119:296-307.
2. van Lint M.T., Uderzo C., Locasciulli A., et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 1998, 92:2288-2293.
3. Mielcarek M., Storer B.E., Boeckh M., et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood 2009, 113:2888-2894.
4. Hings I.M., Filipovich A.H., Miller W.J., et al. Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation 1993, 56:577-580.
5. Martin P.J., Schoch G., Fisher L., et al. Aretrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990, 76:1464-1472.
6. MacMillan M.L., Weisdorf D.J., Wagner J.E., et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant 2002, 8:387-394.
7. Martin P.J., Rizzo J.D., Wingard J.R., et al. First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2012, 18:1150-1163.
8. Dignan F.L., Clark A., Amrolia P., et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol 2012, 158:30-45.
9. Xhaard A., Rocha V., Bueno B., et al. Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. Biol Blood Marrow Transplant 2012, 18:406-413.
10. Greinix H.T., Volc-Platzer B., Kalhs P., et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000, 96:2426-2431.
11. Greinix H.T., Knobler R.M., Worel N., et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006, 91:405-408.
12. Greinix H.T., Worel N., Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:1747-1748.
13. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974, 18:295-304.
14. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc 1958, 53:457-481.
15. Gatza E., Rogers C.E., Clouthier S.G., et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008, 112:1515-1521.
16. Greinix H.T., Socie G., Bacigalupo A., et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006, 38:265-273.
17. MacMillan M.L., DeFor T.E., Weisdorf D.J. The best endpoint for acute GVHD treatment trials. Blood 2010, 115:5412-5417.
18. Martin P.J., Inamoto Y., Flowers M.E., Carpenter P.A. Secondary treatment of acute graft-versus-host disease: a critical review. Biol Blood Marrow Transplant 2012, 18:982-988.